Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab and/or Teriparatide in Japanese Osteoporotic Patients
NCT02156960Phase 4Unknown
- Sponsor
- Shinshu University
- Start
- May 2014
- Primary completion
- May 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab, teriparatide in osteoporosis, sponsored by Shinshu University. Status: unknown.
02
Drugs
denosumabteriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02156960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02156960.